Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Opinion
Video
Overcoming Treatment Barriers in Vitiligo: From Insurance Coverage to Patient Adherence
Author(s):
Andrew Alexis, MD, MPH, reviews the case of a 66-year-old woman who presented with depigmented patches and provides clinical insights on barriers typically encountered during the management of this condition.
Video content above is prompted by the following questions:
- Where would you go from here, treatment-wise?
- What is your experience combining topical therapy with NB-UVB phototherapy?
- What are the unique challenges and benefits of using narrowband UVB phototherapy for vitiligo in patients with darker skin color?
- How do you manage the logistical challenges patients might face with frequent phototherapy sessions?
Related Videos
Related Content
